investors.insysrx.com investors.insysrx.com

investors.insysrx.com

Investor Overview - Investors - INSYS Therapeutics Inc.

INSYS Code of Conduct. INSYS Code of Conduct. We are a specialty pharmaceutical company that develops and commercializes innovative drugs and novel drug delivery systems of therapeutic molecules that improve the quality of patients' lives. Using our proprietary sublingual spray technology and our capability to develop pharmaceutical cannabinoids, Insys addresses the clinical shortcomings of existing commercial products. Insys currently markets two products, Subsys. In March 2012, we launched Subsys.

http://investors.insysrx.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR INVESTORS.INSYSRX.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

June

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Friday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.4 out of 5 with 9 reviews
5 star
4
4 star
0
3 star
3
2 star
0
1 star
2

Hey there! Start your review of investors.insysrx.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

1.4 seconds

CONTACTS AT INVESTORS.INSYSRX.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Investor Overview - Investors - INSYS Therapeutics Inc. | investors.insysrx.com Reviews
<META>
DESCRIPTION
INSYS Code of Conduct. INSYS Code of Conduct. We are a specialty pharmaceutical company that develops and commercializes innovative drugs and novel drug delivery systems of therapeutic molecules that improve the quality of patients' lives. Using our proprietary sublingual spray technology and our capability to develop pharmaceutical cannabinoids, Insys addresses the clinical shortcomings of existing commercial products. Insys currently markets two products, Subsys. In March 2012, we launched Subsys.
<META>
KEYWORDS
1 careers
2 overview
3 apply
4 internship program
5 leadership
6 board of directors
7 corporate compliance
8 compliance program structure
9 compliance helpline
10 approved
CONTENT
Page content here
KEYWORDS ON
PAGE
careers,overview,apply,internship program,leadership,board of directors,corporate compliance,compliance program structure,compliance helpline,approved,in development,science,approach to innovation,clinical trial participation,social responsibility
SERVER
cloudflare-nginx
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Investor Overview - Investors - INSYS Therapeutics Inc. | investors.insysrx.com Reviews

https://investors.insysrx.com

INSYS Code of Conduct. INSYS Code of Conduct. We are a specialty pharmaceutical company that develops and commercializes innovative drugs and novel drug delivery systems of therapeutic molecules that improve the quality of patients' lives. Using our proprietary sublingual spray technology and our capability to develop pharmaceutical cannabinoids, Insys addresses the clinical shortcomings of existing commercial products. Insys currently markets two products, Subsys. In March 2012, we launched Subsys.

OTHER SITES

investors.innovation-group.com investors.innovation-group.com

Investors – Innovation Group

Skip to main content. First Notice of Loss (FNOL). Emergency Tow and Roadside. Subrogation and Adverse Subrogation. Motor Services Online Tracking. Claims Management Services - Property. Fleet Maintain and Comparator. Innovation Group at a Glance. Key Risks and Uncertainties. Rest of Europe Regional Review. South Africa Regional Review. North America Regional Review. Asia Pacific Regional Review. 5 Year Profit and Loss. KPIs and Business Drivers. First Notice of Loss (FNOL). Emergency Tow and Roadside.

investors.inphi.com investors.inphi.com

Investor Relations - Inphi

Inphi Corp at Oppenheimer 18th Annual Technology, Internet and Communications Conference. 160;at 2:25 pm ET. Inphi Corp at Oppenheimer 18th Annual Technology, Internet and Communications Conference. Wednesday, August 12, 2015 . 2:25 pm ET  . Click here for webcast. Click here to add this event to your calendar. Inphi is a leading provider of high-speed, mixed signal semiconductor solutions for the communications and computing markets. Inphi’s solutions provide a vi. 160; 0.62. Minimum 20 minute delay.

investors.installedbuildingproducts.com investors.installedbuildingproducts.com

Installed Building Products Inc. - Investor Relations

Closets & Shelving. Shower Doors, Mirrors & Bath Hardware. Door Locksets & Hardware. Annual Meeting of Stockholders. Stock Quote (NYSE: IBP). 4:02 PM ET on Aug 14, 2015. Delayed at least 20 minutes. View all ». Aug 10, 2015. Installed Building Products Announces the Acquisition of an Insulation Installer with Locations in New Jersey and Texas. Jul 29, 2015. Installed Building Products Reports Results for Second Quarter 2015. Shower Doors, Mirrors and Bath Hardware. Door Locksets and Hardware.

investors.instem.com investors.instem.com

Instem Investor Centre

A global provider of leading software solutions. And services to the life sciences community. Helping our clients bring life enhancing products to market faster. Creating a more connected ecosystem in the. Life sciences industry by consolidating and. Harmonizing a fragmented IT marketplace. Welcome to the Instem Investor Centre. 26 March 2018 - Unaudited Results for the Year Ended 31 December 2017. 26 March 2018 - SEND Contract Extension and SEND Update. A Decade in Perspective. A Decade in Perspective.

investors.insulet.com investors.insulet.com

Investor Relations | Insulet Corporation

Skip to main navigation. SIGN UP FOR ALERTS. IR and Media Contact:. Deborah R. Gordon, C.P.A. Investor Relations and Corporate Communications. 600 Technology Park Dr. Billerica, MA 01821-4150. Stock Quote (: ). Studies have demonstrated the advantages of insulin pump therapy over multiple daily insulin injections (MDI); these advantages include better glycemic control, fewer hypoglycemic events, reduced glycemic variability. And improved quality of life. 1 Diabetes Control and Complications Trial Researc...

investors.insysrx.com investors.insysrx.com

Investor Overview - Investors - INSYS Therapeutics Inc.

INSYS Code of Conduct. INSYS Code of Conduct. We are a specialty pharmaceutical company that develops and commercializes innovative drugs and novel drug delivery systems of therapeutic molecules that improve the quality of patients' lives. Using our proprietary sublingual spray technology and our capability to develop pharmaceutical cannabinoids, Insys addresses the clinical shortcomings of existing commercial products. Insys currently markets two products, Subsys. In March 2012, we launched Subsys.

investors.interactivebrokers.com investors.interactivebrokers.com

IBKR Investor Relations Information Services

Financial and Operating Info. IBKR aims to provide an exceptionally inexpensive and versatile platform for our clients to manage their finances. It is vitally important to us that our clients be better equipped, pay lower prices, and have other advantages so as to generate higher returns than the customers of other brokers. You may be considering investing in IBKR. We would like to ask you not to buy our shares unless you become an active user of our platform prior to doing so. March 1, 2018. 1-800-662-7...

investors.interpublic.com investors.interpublic.com

interpublic investors summary | IPG

Job openings at IPG corporate. Community outreach / volunteering. 160; 0.15. Data as of 08/07/15 4:01 pm ET. Minimum 20 minute delay. Interpublic Group (IPG) is one of the world’s premier global advertising, and marketing services companies. Through our 48,400 employees in all major world markets, our companies specialize in consumer advertising, digital marketing, communications planning and media buying, public relations and specialized communications disciplines. IPG Presents 2015 Inclusion Awards.

investors.interxion.com investors.interxion.com

Interxion | Investor Relations | Investor Relations Homepage

We're a leading provider of cloud- and carrier-neutral colocation data centres in Europe. We support over 1,200 customers through 29 data centres across 11 countries. Read about the history of Interxion and our vision for the future. Learn about the people behind our success. How to find us. Find an office near you. Interxion on Social Media. Read more about each of the countries we're based in and each city's data centres here. What is a carrier-neutral data centre. Why outsource your data centre? Befor...

investors.intrepidpotash.com investors.intrepidpotash.com

Intrepid Potash > Investor Relations > Investor Relations

07/28/15  Intrepid Potash Announces Second Quarter and First Half 2015 Results. Stock Info - IPI (Common Stock). Change (%):  - 0.04. 08/07/15 4:00 pm ET. Minimum 20 minute delay. Powered By EDGAR Online. Click here to see our history. 160; 0.04. Data as of 08/07/15 4:00 pm ET. Minimum 20 minute delay. Intrepid Potash Announces Second Quarter and First Half 2015 Results. Intrepid Potash Announces Date for Second Quarter Earnings Release. Intrepid Potash to Present at BMO Farm to Market Conference.

investors.investarbank.com investors.investarbank.com

Investar Bank > Investor Relations

Open an Account Online. E-Savings and E-Money Market. Savings and Money Market. Savings, CDs, Money Market. Home Equity Loans / Lines. Contact Us - Investors. Day High: 15.90. Day Low: 15.75. Aug 14, 2015. Delayed 20 min., by eSignal. Investor Relations" onclick="window.open('http:/ www.facebook.com/share.php? U=http:/ investors.investarbank.com/index.cfm? Investor Relations" onclick="window.open('https:/ plus.google.com/share? Url=http:/ investors.investarbank.com/index.cfm? Jul 28, 2015. Jun 18, 2015.